Skip to Main Content

Paper Details

Down-regulation of ADRB2 expression is associated with small cell neuroendocrine prostate cancer and adverse clinical outcomes in castration-resistant prostate cancer.
Urol Oncol
3
2020
2-adrenergic receptor ADRB2, ADRB2, EZH2, Patients, RNA, castration-resistant prostate cancer, histology, mCRPC, metastatic castration-resistant prostate cancer, patients, small cell, small cell neuroendocrine prostate cancer, small cell-enriched transcriptional cluster, tumors
Author NameAffiliation
David A QuigleyUniversity of California san francisco
Adam FoyeUniversity of California san francisco
Christopher K WongDepartment of Biomolecular Engineering and UC Santa Cruz Genomics Institute, University of California
Felix Y FengUniversity of California san francisco
Jiaoti HuangDuke University
Joshua M StuartDepartment of Biomolecular Engineering and UC Santa Cruz Genomics Institute, University of California
Joshua M StuartDepartment of Biomolecular Engineering and UC Santa Cruz Genomics Institute, University of California
Alana S WeinsteinDepartment of Biomolecular Engineering and UC Santa Cruz Genomics Institute, University of California
Tomasz M BeerOregon Health & Science University
Joshi J AlumkalUniversity of Michigan ann arbor
Matthew B RettigUniversity of California los angeles
Martin E GleaveUniversity of British Columbia
Primo N LaraUniversity of California davis
George V ThomasOregon Health & Science University
Eric J SmallUniversity of California san francisco
Rahul AggarwalUniversity of California san francisco
  • 1 - 16

Datasets

Release 1.2